|
|
|
| Research advances in early markers for the diagnosis of acute kidney injury |
| HAN Yunbiao1 ZHAO Yiwen2 XU Libin1 |
1.Inner Mongolia Clinical Medical College, Inner Mongolia Medical University, Inner Mongolia Autonomous Region, Hohhot 010010, China;
2.Department of Nephrology, Inner Mongolia Autonomous Region People’s Hospital, Inner Mongolia Autonomous Region, Hohhot 010010, China |
|
|
|
|
Abstract Acute kidney injury (AKI) is an acute and critical illness in the department of nephrology. Although most physicians have improved their understanding of AKI, there is still a high missed diagnosis rate and mortality rate. Some patients may experience chronic changes. Creatinine and urine volume is the main diagnostic indicator, which is single and hysteresis, lacks the specificity of renal tubular injury, and is easily disturbed by many factors. It is difficult to evaluate AKI early, but with the discovery of some early markers, the early diagnosis and treatment of AKI is possible. This paper summarizes some of the new diagnostic markers, describes the possible pathophysiological processes of different markers in AKI, expounds the feasibility of predicting AKI with some markers, and proposes some checking points for AKI treatment, which will provide guidance for the diagnosis and treatment of AKI in the future.
|
|
|
|
|
|
[1] Yang L，Besschetnova TY，Brooks CR，et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury [J]. Nat Med，2010，16（5）：535-543，143.
[2] Khan MGM，Wang Y. Cell cycle-related clinical applications [J]. Methods Mol Biol，2022，2579：35-46.
[3] Wang Y，Zou Z，Jin J，et al. Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery [J]. BMC Nephrol，2017，18（1）：177.
[4] 唐凯宏，金英玉.尿金属蛋白酶组织抑制剂-2·胰岛素样生长因子结合蛋白-7对脓毒血症患者急性肾损伤和肾替代治疗的早期预测价值[J].国际检验医学杂志，2021，42（4）：476-480.
[5] G?觟cze I，Jauch D，G?觟tz M，et al. Biomarker-guided intervention to prevent acute kidney injury after major surgery：the prospective randomized BigpAK study [J]. Ann Surg，2018， 267（6）：1013-1020.
[6] Von Groote T，Meersch M，Romagnoli S，et al. Biomarker- guided intervention to prevent acute kidney injury after major surgery （BigpAK-2 trial）：study protocol for an international，prospective，randomised controlled multicentre trial [J]. BMJ Open，2023，13（3）：e070240.
[7] Zhao T，Su Z，Li Y，et al. Chitinase-3 like-protein-1 function and its role in diseases [J]. Signal Transduct Target Ther， 2020，5（1）：201.
[8] Hall IE，Stern EP，Cantley LG，et al. Urine YKL-40 is associated with progressive acute kidney injury or death in hospitalized patients [J]. BMC Nephrol，2014，15：133.
[9] Hoste EA，Vaara ST，De Loor J，et al. Urinary cell cycle arrest biomarkers and chitinase 3-like protein 1 （CHI3L1） to detect acute kidney injury in the critically ill：a post hoc laboratory analysis on the FINNAKI cohort [J]. Crit Care，2020， 24（1）：144.
[10] Schmidt IM，Hall IE，Kale S，et al. Chitinase-like protein Brp-39/YKL-40 modulates the renal response to ischemic injury and predicts delayed allograft function [J]. J Am Soc Nephrol，2013，24（2）：309-319.
[11] Vandenberghe W，De Loor J，Francois K，et al. Potential of urine biomarkers CHI3L1，NGAL，TIMP-2，IGFBP7，and combinations as complementary diagnostic tools for acute kidney injury after pediatric cardiac surgery：a prospective cohort study [J]. Diagnostics（Basel），2023，13（6）：1047.
[12] Montgomery TA，Xu L，Mason S，et al. Breast regression protein-39/Chitinase 3-like 1 promotes renal fibrosis after kidney injury via activation of myofibroblasts [J]. J Am Soc Nephrol，2017，28（11）：3218-3226.
[13] Piek A，Smit L，Suthahar N，et al. The emerging plasma biomarker Dickkopf-3 （DKK3） and its association with renal and cardiovascular disease in the general population [J]. Sci Rep，2021，11（1）：8642.
[14] Schunk SJ，Zarbock A，Meersch M，et al. Association between urinary dickkopf-3，acute kidney injury，and subsequent loss of kidney function in patients undergoing cardiac surgery：an observational cohort study [J]. Lancet，2019，394 （10197）：488-496.
[15] 孙泽源，鄢高亮，王栋，等.血及尿DKK3在造影剂所致急性肾损伤中的预测价值[J].现代医学，2022，50（6）：672-676.
[16] Schunk SJ，Beisswenger C，Ritzmann F，et al. Measurement of urinary Dickkopf-3 uncovered silent progressive kidney injury in patients with chronic obstructive pulmonary disease [J]. Kidney Int，2021，100（5）：1081-1091.
[17] Ploug M，R?覬nne E，Behrendt N，et al. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol [J]. J Biol Chem，1991，266（3）：1926-1933.
[18] Thun?覬 M，Macho B，Eugen-Olsen J. suPAR：the molecular crystal ball [J]. Dis Markers，2009，27（3）：157-172.
[19] 朱龙银，王海霞，程伟，等.血浆suPAR及尿NGAL、KIM-1对成人心脏手术相关性急性肾损伤的早期诊断价值[J].解放军医学杂志，2021，46（12）：1205-1212.
[20] Huang Y，Huang S，Zhuo X，et al. Predictive value of suPAR in AKI：a systematic review and meta-analysis [J]. Clin Exp Nephrol，2023，27（1）：1-11.
[21] Schenk H，Müller-Deile J，Schmitt R，et al. Removal of focal segmental glomerulosclerosis （FSGS） factor suPAR using CytoSorb [J]. J Clin Apher，2017，32（6）：444-452.
[22] Wei C，Spear R，Hahm E，et al. suPAR，a circulating kidney disease factor [J]. Front Med （Lausanne），2021，8：745838.
[23] Kim EY，Dryer SE. RAGE and αVβ3-integrin are essential for suPAR signaling in podocytes [J]. Biochim Biophys Acta Mol Basis Dis，2021，1867（10）：166186.
[24] Hayek SS，Leaf DE，Samman Tahhan A，et al. Soluble urokinase receptor and acute kidney injury [J]. N Engl J Med， 2020，382（5）：416-426.
[25] 何星，王富博，叶华茂.外泌体在肾脏疾病中的研究进展[J].海军医学杂志，2021，42（2）：253-256.
[26] 谢安妮，余燕婷，王晓燕.长链非编码RNA在急性肾损伤中的研究进展[J].中国医药导报，2022，19（27）：47-49.
[27] Melkonyan HS，Feaver WJ，Meyer E，et al. Transrenal nucleic acids：from proof of principle to clinical tests [J]. Ann N Y Acad Sci，2008，1137：73-81.
[28] Thongboonkerd V，Kanlaya R. The divergent roles of exosomes in kidney diseases：pathogenesis，diagnostics，prognostics and therapeutics [J]. Int J Biochem Cell Biol，2022， 149：106262.
[29] Sonoda H，Oshikawa-Hori S，Ikeda M. An early decrease in release of aquaporin-2 in urinary extracellular vesicles after cisplatin treatment in rats [J]. Cells，2019，8（2）：139.
[30] Thongboonkerd V. Roles for exosome in various kidney diseases and disorders [J]. Front Pharmacol，2020，10：1655.
[31] Gao F，Zuo B，Wang Y，et al. Protective function of exosomes from adipose tissue-derived mesenchymal stem cells in acute kidney injury through SIRT1 pathway [J]. Life Sci，2020，255：117719.
[32] Eirin A，Zhu XY，Puranik AS，et al. Mesenchymal stem ce- llderived extracellular vesicles attenuate kidney inflammation [J]. Kidney Int，2017，92（1）：114-124.
[33] Xu S，Cheuk YC，Jia Y，et al. Bone marrow mesenchymal stem cell-derived exosomal miR-21a-5p alleviates renal fibrosis by attenuating glycolysis by targeting PFKM [J]. Cell Death Dis，2022，13（10）：876.
[34] 严涛，夏晓华，高勤昌，等.血清sKlotho、HGF水平与体外心肺复苏后发生急性肾损伤的关系[J].疑难病杂志，2022，21（7）：716-720.
[35] 李引弟，宋渊丽，李雪峰.血清肝细胞生长因子和富亮氨酸α2糖蛋白1水平与子痫前期及急性肾损伤的相关性分析[J].中国医药，2023，18（4）：555-559.
[36] Li L，An JN，Lee J，et al. Hepatocyte growth factor and soluble cMet levels in plasma are prognostic biomarkers of mortality in patients with severe acute kidney injury [J]. Kidney Res Clin Pract，2021，40（4）：596-610.
[37] Cheng G，Tang X，Zhang J. Hepatocyte growth factor exerts beneficial effects on mice with type Ⅱ diabetes induced chronic renal failure via the NF-κB pathway [J]. Mol Med Rep，2018，18（3）：3389-3396.
[38] Sun Y，Fan Y，Wang Z，et al. S100A16 promotes acute kidney injury by activating HRD1-induced ubiquitination and degradation of GSK3β and CK1α [J]. Cell Mol Life Sci，2022， 79（3）：184.
[39] Chen S，Zhang M，Li J，et al. β-catenin-controlled tubular cell-derived exosomes play a key role in fibroblast activation via the OPN-CD44 axis [J]. J Extracell Vesicles，2022， 11（3）：e12203.
[40] Askenazi DJ，Montesanti A，Hundley H，et al. Urine biomar- kers predict acute kidney injury and mortality in very low birth weight infants [J]. J Pediatr，2011，159（6）：907.e1-912.e1.
[41] Askenazi DJ，Koralkar R，Patil N，et al. Acute kidney injury urine biomarkers in very low-birth-weight infants [J]. Clin J Am Soc Nephrol，2016，11（9）：1527-1535.
[42] Van Nynatten LR，Slessarev M，Martin CM，et al. Novel plasma protein biomarkers from critically ill sepsis patients [J]. Clin Proteomics，2022，19（1）：50.
[43] Kohl K，Herzog E，Dickneite G，et al. Evaluation of urinary biomarkers for early detection of acute kidney injury in a rat nephropathy model [J]. J Pharmacol Toxicol Methods，2020， 105：106901.
[44] Cen C，Aziz M，Yang WL，et al. Osteopontin blockade attenuates renal injury after ischemia reperfusion by inhibiting NK cell infiltration [J]. Shock，2017，47（1）：52-60.
[45] 张亚楠.血清胱抑素C与肌酐、尿素氮联合检测对肾功能损害的诊断价值[J].中国医药指南，2022，20（27）：106-108. |
|
|
|
